On Friday, the Food and Drug Administration granted approval for COVID-19 vaccines to be administered to infants as young as six months old. It paves the way for the administration of vaccinations to 20 million infants, toddlers, and preschool-aged children.
Before vaccinations can be administered to children younger than 5 years old, the Centers for Disease Control and Prevention (CDC) must first give their approval. This might take place in the next several days.
“Those trusted with the care of children can have confidence in the safety and effectiveness of these COVID-19 vaccines. And can be assured that the agency was thorough in its evaluation of the data,” FDA Commissioner Dr. Robert Califf said in a statement announcing the move.
Wednesday’s meeting lasted all day, and at the end of it, all attendees gave their unanimous approval to the FDA’s decision. During the meeting, both the outside advisers retained by the regulatory body and the Vaccines and Related Biological Products Advisory Committee were present. The proposals made by Pfizer, Moderna, and their joint venture partner BioNTech were evaluated by the officials.
Obviously, there are no studies that last for a very long time.
The preceding is a summary of an article that originally appeared on IndependentSentinel.